life science investing RETRANSMISSION: Defence Breakthrough: Successfully Engineered Accum-mRNA Vaccine Creating a New Vaccine Platform. The in vivo Accum-mRNA Cancer Vaccine Program Begins
life science investing Defence Breakthrough: Successfully Engineered Accum-mRNA Vaccine Creating a New Vaccine Platform. The in vivo Accum-mRNA Cancer Vaccine Program Begins
life science investing Defence to Complete a Final Pre-Clinical Study Prior to IND Filings for the AccuTOX Phase I Cancer Trial at the City of Hope National Medical Center and Beckman Research Institute
life science investing Defence Therapeutics Announces Exercise of Warrants for Gross Proceeds of over $5 Million
